ArticleFuture oncology (London, England)2025

Programmed cell death ligand 1 (PD-L1) inhibitors versus programmed cell death 1 (PD-1) inhibitors for the first-line therapy of extensive-stage small cell lung cancer: a propensity score-matched study.

Zhuoran Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.